Xiang Gao

3.6k total citations · 1 hit paper
95 papers, 2.8k citations indexed

About

Xiang Gao is a scholar working on Molecular Biology, Biomaterials and Immunology. According to data from OpenAlex, Xiang Gao has authored 95 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 26 papers in Biomaterials and 17 papers in Immunology. Recurrent topics in Xiang Gao's work include Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (21 papers) and Nanoplatforms for cancer theranostics (14 papers). Xiang Gao is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (21 papers) and Nanoplatforms for cancer theranostics (14 papers). Xiang Gao collaborates with scholars based in China, United States and Hong Kong. Xiang Gao's co-authors include Yuquan Wei, Zhiyong Qian, Anwei Zhu, Changqin Ding, Yang Tian, Bilan Wang, Gang Guo, Ting Yu, Bilan Wang and Yuzhu Hu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

In The Last Decade

Xiang Gao

87 papers receiving 2.7k citations

Hit Papers

Current advance of nanotechnology in diagnosis and treatm... 2024 2026 2025 2024 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang Gao China 31 1.1k 758 704 453 375 95 2.8k
Ke Men China 32 1.1k 1.0× 882 1.2× 547 0.8× 299 0.7× 431 1.1× 82 2.7k
Xinru You China 30 900 0.8× 918 1.2× 859 1.2× 214 0.5× 247 0.7× 61 2.4k
Daquan Chen China 35 1.3k 1.1× 961 1.3× 1.0k 1.5× 246 0.5× 341 0.9× 121 3.5k
Meiwan Chen Macao 28 1.1k 1.0× 553 0.7× 915 1.3× 221 0.5× 278 0.7× 96 2.7k
Xiaoye Yang China 35 869 0.8× 1.2k 1.5× 1.3k 1.8× 253 0.6× 252 0.7× 90 3.0k
Guangya Xiang China 34 1.6k 1.4× 1.1k 1.5× 1.2k 1.7× 479 1.1× 355 0.9× 98 3.6k
Longfa Kou China 37 1.5k 1.4× 1.2k 1.6× 983 1.4× 491 1.1× 406 1.1× 109 4.0k
Sanjun Shi China 30 1.2k 1.1× 768 1.0× 876 1.2× 346 0.8× 200 0.5× 66 2.9k
Yu Cai China 27 877 0.8× 618 0.8× 497 0.7× 377 0.8× 287 0.8× 76 2.5k

Countries citing papers authored by Xiang Gao

Since Specialization
Citations

This map shows the geographic impact of Xiang Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Gao more than expected).

Fields of papers citing papers by Xiang Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Gao. The network helps show where Xiang Gao may publish in the future.

Co-authorship network of co-authors of Xiang Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Gao. A scholar is included among the top collaborators of Xiang Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Gao. Xiang Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yixin, Lianlian Wu, Xiang Gao, et al.. (2025). Machine learning reshapes the paradigm of nanomedicine research. Acta Pharmaceutica Sinica B. 16 indexed citations
2.
Zhou, Wenjie, Yunchu Zhang, Xijing Yang, et al.. (2024). Apatinib potentiates doxorubicin with cRGD-functionalized pH-sensitive micelles against glioma. Chinese Chemical Letters. 36(5). 110084–110084. 3 indexed citations
3.
Chen, Junli, et al.. (2024). Red blood cell membrane-coated FLT3 inhibitor nanoparticles to enhance FLT3-ITD acute myeloid leukemia treatment. Chinese Chemical Letters. 35(9). 109779–109779. 4 indexed citations
4.
Zhang, Fan, et al.. (2024). Mantle serpentinization of subducting plate are controlled by combined effect of plate age and bending curvature. Earth and Planetary Science Letters. 640. 118799–118799. 3 indexed citations
5.
Wang, Wanyu, Wenjie Zhou, Zhongxin Duan, et al.. (2024). A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy. Small. 20(30). e2400630–e2400630. 15 indexed citations
6.
Wang, Bilan, Shiqi Hu, Yan Teng, et al.. (2024). Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduction and Targeted Therapy. 9(1). 200–200. 238 indexed citations breakdown →
7.
Duan, Zhongxin, Yunchu Zhang, Yunchu Zhang, et al.. (2023). Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy. Acta Pharmaceutica Sinica B. 14(2). 854–868. 16 indexed citations
8.
Zhang, Shuheng, Xifeng Zhang, Hongyi Huang, et al.. (2023). Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer. Small Methods. 8(1). e2301127–e2301127. 18 indexed citations
9.
Zhang, Yunchu, Yunchu Zhang, Tingting Li, et al.. (2021). Co-delivery of doxorubicin and curcumin via cRGD-peptide modified PEG-PLA self-assembly nanomicelles for lung cancer therapy. Chinese Chemical Letters. 33(5). 2507–2511. 36 indexed citations
10.
Gao, Yan, Ke Men, Jieping Wu, et al.. (2021). Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy. International Journal of Nanomedicine. Volume 16. 5211–5232. 35 indexed citations
11.
Yan, Yi, Lin Zhai, Jing Sun, et al.. (2021). Enhanced cancer therapeutic efficiency of NO combined with siRNA by caspase-3 responsive polymers. Journal of Controlled Release. 339. 506–520. 14 indexed citations
12.
Yu, Ting, Wen Nie, Yihong He, et al.. (2021). Synergy of Immunostimulatory Genetherapy with Immune Checkpoint Blockade Motivates Immune Response to Eliminate Cancer. Advanced Functional Materials. 31(22). 32 indexed citations
13.
Liu, Yan, et al.. (2019). Apatinib-induced hyperammonemic encephalopathy. Journal of Oncology Pharmacy Practice. 26(2). 465–470. 8 indexed citations
14.
Zhou, Peizhi, Yue Cao, Xiaoxiao Liu, et al.. (2018). Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1. International Journal of Nanomedicine. Volume 13. 4781–4793. 10 indexed citations
15.
Gao, Xiang, et al.. (2017). Role of calcifying nanoparticles in the development of testicular microlithiasis in vivo. BMC Urology. 17(1). 99–99. 3 indexed citations
16.
Hu, Tingting, Hua Cao, Chengli Yang, et al.. (2016). LHD-Modified Mechanism-Based Liposome Coencapsulation of Mitoxantrone and Prednisolone Using Novel Lipid Bilayer Fusion for Tissue-Specific Colocalization and Synergistic Antitumor Effects. ACS Applied Materials & Interfaces. 8(10). 6586–6601. 21 indexed citations
17.
Gao, Xiang, Changqin Ding, Anwei Zhu, & Yang Tian. (2014). Carbon-Dot-Based Ratiometric Fluorescent Probe for Imaging and Biosensing of Superoxide Anion in Live Cells. Analytical Chemistry. 86(14). 7071–7078. 202 indexed citations
18.
Gao, Xiang, Gou, Meijuan Huang, et al.. (2013). Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer. International Journal of Nanomedicine. 8. 971–971. 70 indexed citations
19.
Gao, Xiang, Fengjin Zheng, Gang Guo, et al.. (2013). Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles. Journal of Materials Chemistry B. 1(42). 5778–5778. 51 indexed citations
20.
Gong, Changyang, Senyi Deng, Qinjie Wu, et al.. (2012). Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials. 34(4). 1413–1432. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026